DAY 1 - Friday, April 19
Welcome
Ophthalmology Times welcomes ophthalmic professionals from around the world to San Francisco. Our four-day coverage of this year’s meeting of the American Society of Cataract and Refractive Surgery begins today and includes the latest research findings and clinical news of interest to readers.
Enjoy the meeting!
CORNEA DAY
An evidence-based approach to dry eye
Much of the guesswork about how to manage dry eye disease was clarified by the results of the Dry Eye Workshop, which established a practical, easy-to-use assessment tool and stepwise treatment approach, said Deepinder Dhaliwal, MD. » MORE
Limbal cell deficiency more common
Contact lens wear, eye drops for glaucoma, treatment with mitomycin C, thermal trauma, and a variety of common events can cause limbal cell deficiency, said Edward Holland, MD. » MORE
BLOG FROM ASCRS
Front row seat to the stage of innovation
With all the new technology and ideas that will surface here in San Francisco over the next four days, Ophthalmology Times has a front row seat to the stage of innovation. » MORE
GLAUCOMA DAY
Sustained-release medications on the way
A new generation of drug delivery devices promises to make eye drops the drug delivery vehicle of the past. "We would all like to see better . . . extended-release treatments that get us around persistence and adherence issues. And they are on the way," said Ike Ahmed, MD. » MORE
Cataract surgery in glaucoma intervention
Cataract surgery is already the most-used intervention for glaucoma. A growing number of glaucoma specialists want to see timely glaucoma surgery accepted and reimbursed as an appropriate intervention for the long-term management of glaucoma, said Kuldev Singh, MD, MPH. » MORE
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
|
